Proton-pump inhibitors (e.g., omeprazole, esomeprazole, and lansoprazole), used to treat Zollinger-Ellison syndrome and gastroesophageal reflux disease (GERD), markedly decrease stomach acid secretion required for the release of vitamin B 12 from food but not from supplements
ADVANCED BRIGHTENING: Targets the enzymatic root of hyperpigmentation (Tyrosinase) to promote a naturally lighter, more luminous complexion
The July 2026 FDA advisory committee vote outcome for ulcerative colitis was pending at last check
Plantone D, Primiano G, Manco C, Locci S, Servidei S, De Stefano N
Angiogenesis Support: BPC-157 appears to promote the formation of new blood vessels, thereby expediting and enhancing oxygen and nutrient flow to injured tissues